CRESCENT BIOPHARMA, INC.
CBIO
20 insider filings · Latest: Sep 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Jun 23 8:01 PM | Joshua T BrummDirector, Chief Executive Officer | Sale | 42,305 | $17.99 | $761.1K | 281,212(D) | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Jul 20 9:30 PM | Fairmount Funds Management LLCDirector, 10% Owner | Purchase | 525,897 | $0.001 | 2,294,037(I) | View → |
| Jun 2, 2026 | Jun 3 11:48 PM | Jonathan ViolinDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:48 PM | David Charles LubnerDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:47 PM | Alexandra BalcomDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:47 PM | Susan MoranDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:46 PM | Fairmount Funds Management LLCDirector, 10% Owner | Grant/Award | 11,050 | $17.01 | 11,050(I) | View → |